Triatomic Management LP - ADAGIO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Triatomic Management LP ownership history of ADAGIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$43,860
+61.9%
25,8000.0%0.03%
+7.1%
Q2 2023$27,090
-12.5%
25,8000.0%0.03%
+33.3%
Q1 2023$30,960
-20.0%
25,8000.0%0.02%
-36.4%
Q4 2022$38,700
-52.2%
25,8000.0%0.03%
-29.8%
Q3 2022$81,000
-4.7%
25,8000.0%0.05%
-39.7%
Q2 2022$85,000
-28.0%
25,8000.0%0.08%
-18.8%
Q1 2022$118,000
-36.9%
25,8000.0%0.10%
-16.5%
Q4 2021$187,00025,8000.12%
Other shareholders
ADAGIO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 9,248,250$9,710,66312.83%
Alphabet Inc. 5,680,785$5,964,8240.32%
683 Capital Management, LLC 4,000,000$4,200,0000.30%
Bain Capital Life Sciences Investors, LLC 1,937,207$2,034,0670.21%
TANG CAPITAL MANAGEMENT LLC 1,151,843$1,209,4350.18%
Slate Path Capital LP 3,735,000$3,921,7500.14%
BML Capital Management, LLC 134,696$141,4310.13%
Orbimed Advisors 5,270,400$5,533,9200.10%
Redmile Group, LLC 1,440,725$1,512,7610.06%
MAVERICK CAPITAL LTD 2,338,373$2,455,2920.05%
View complete list of ADAGIO THERAPEUTICS INC shareholders